External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Roche and Genentech at

IUSG 2026

July 09 - July 11

Tubingen, Germany

iusg.net

We will be contributing to topics related to

Ophthalmology

Add to calendar

Agenda

Medical Materials

06:00 AM

Duration 60mins Tubingen, Germany

Interleukin-6 Mediated Pathways in Uveitic Macular Edema: Molecular Insights and Therapeutic Response to Vamikibart

Zeinab Barekati

Ophthalmology | Uveitic Macular Edema

Notify me

Add to calendar

Duration 60mins Tubingen, Germany

Baseline Characteristics of Participants with Uveitic Macular Edema in the Vamikibart Phase 3 MEERKAT and SANDCAT Trials

Steven Yeh

Ophthalmology | Uveitic Macular Edema

Notify me

Add to calendar

Duration 60mins Tubingen, Germany

IL-6 Inhibition With Vamikibart in Patients With Uveitic Macular Edema: Study Design of the Phase 3 MEERKAT and SANDCAT Trials

Rebecca Kaye

Ophthalmology | Uveitic Macular Edema

Notify me

Add to calendar

01:14 PM

Duration 8mins Tubingen, Germany

Efficacy and Safety of Vamikibart in Patients With Uveitic Macular Edema: First Report of Pooled Phase 3 MEERKAT and SANDCAT Trials

Lyndell Lim

Ophthalmology | Uveitic Macular Edema

Notify me

Add to calendar

Coming soon

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.